Lloyd Sanders

Director Ejecutivo en Epic Sciences, Inc. .

Health Technology

Perfil

Lloyd Sanders is currently the President, Chief Executive Officer & Director at Epic Sciences, Inc. He previously worked as the Chief Operating Officer at Mylan Specialty LP.

Cargos activos de Lloyd Sanders

Empresas	Cargo	Inicio
Epic Sciences, Inc. Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA.	Director Ejecutivo	25/03/2019

Todos los cargos activos de Lloyd Sanders

Antiguos cargos conocidos de Lloyd Sanders.

Empresas	Cargo	Fin
Mylan Specialty LP Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV.	Director de Operaciones	-

Ver el detalle de la experiencia de Lloyd Sanders.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lloyd Sanders.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Mylan Specialty LP Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV.	Health Technology
Epic Sciences, Inc. Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA.	Health Technology